Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Rivastigmine

123441-03-2C14H22N2O2250.342 g/mol

A carbamate ester obtained by formal condensation of the carboxy group of ethyl(methyl)carbamic acid with the phenolic OH group of 3-[(1S)-1-(dimethylamino)ethyl]phenol. A reversible cholinesterase inhibitor. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number123441-03-2ChEBI ↗
Molecular formulaC14H22N2O2ChEBI ↗
Molar mass250.342 g/molChEBI ↗
Monoisotopic mass250.16813 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:8874ChEBI ↗

Cross-source molecular data

PubChem
Molar mass250.34 g/molPubChem ↗
Exact mass250.168127949 DaPubChem ↗
Computed XLogP2.3PubChem ↗
Topological polar surface area (Ų)32.8PubChem ↗
H-bond donors0PubChem ↗
H-bond acceptors3PubChem ↗
Rotatable bonds5PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
rivastigmine
3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
XSVMFMHYUFZWBK-NSHDSACASA-N
CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1
InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1

Names & synonyms

3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antidepressantanxiolytic drugantipsychotic agentEC 3.1.1.8 (cholinesterase) inhibitorcholinergic drugantiparkinson drugneuroprotective agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00399454 mol

Uses 250.342 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 14 atoms
67.17%
O
Oxygen · 2 atoms
12.78%
N
Nitrogen · 2 atoms
11.19%
H
Hydrogen · 22 atoms
8.86%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Rivastigmine transdermal patch: role in the management of Alzheimer's disease. ↗The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists · 2008 Aug · PMID 19032006
Rivastigmine for Alzheimer's disease. ↗The Cochrane database of systematic reviews · 2009 Apr 15 · PMID 19370562
DE3805744 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
EP1980552 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
EP2233465 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:8874

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 77991 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.